This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2007 Oct;48(10):1888-90.

doi: 10.1080/10428190701606859.

Mobilization regimens prior to stem-cell collection in patients with lymphoma: how to choose?

Avichai Shimoni¹, Izhar Hardan

Affiliations

PMID: 17917954
DOI: 10.1080/10428190701606859

Comment

Mobilization regimens prior to stem-cell collection in patients with lymphoma: how to choose?

Avichai Shimoni et al. Leuk Lymphoma. 2007 Oct.

. 2007 Oct;48(10):1888-90.

doi: 10.1080/10428190701606859.

Authors

Avichai Shimoni¹, Izhar Hardan

Affiliation

¹ The Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Israel. ashimoni@sheba.health.gov.il

PMID: 17917954
DOI: 10.1080/10428190701606859

No abstract available

PubMed Disclaimer

Comment on

Intermediate dose etoposide plus G-CSF 16 g/kg is more effective than cyclophosphamide 4 g/m(2) plus G-CSF 10 g/kg in PBSC mobilization of lymphoma patients.
Milone G, Leotta S, Battiato K, Murgano P, Mercurio S, Strano A, Poidomani M, Coppoletta S, Mauro E, Avola G, Pinto V, Camuglia MG, Giustolisi R. Milone G, et al. Leuk Lymphoma. 2007 Oct;48(10):1950-60. doi: 10.1080/10428190701573240. Leuk Lymphoma. 2007. PMID: 17917963 Clinical Trial.

Similar articles

Diabetes impairs hematopoietic stem cell mobilization by altering niche function.
Ferraro F, Lymperi S, Méndez-Ferrer S, Saez B, Spencer JA, Yeap BY, Masselli E, Graiani G, Prezioso L, Rizzini EL, Mangoni M, Rizzoli V, Sykes SM, Lin CP, Frenette PS, Quaini F, Scadden DT. Ferraro F, et al. Sci Transl Med. 2011 Oct 12;3(104):104ra101. doi: 10.1126/scitranslmed.3002191. Sci Transl Med. 2011. PMID: 21998408 Free PMC article.
High-dose etoposide plus granulocyte colony-stimulating factor as an effective chemomobilization regimen for autologous stem cell transplantation in patients with non-Hodgkin Lymphoma previously treated with CHOP-based chemotherapy: a study from the Consortium for Improving Survival of Lymphoma.
Hyun SY, Cheong JW, Kim SJ, Min YH, Yang DH, Ahn JS, Lee WS, Ryoo HM, Do YR, Lee HS, Lee JH, Oh SY, Suh C, Yhim HY, Kim JS. Hyun SY, et al. Biol Blood Marrow Transplant. 2014 Jan;20(1):73-9. doi: 10.1016/j.bbmt.2013.10.012. Epub 2013 Oct 17. Biol Blood Marrow Transplant. 2014. PMID: 24141009
Beyond CD34+ cell dose: impact of method of peripheral blood hematopoietic stem cell mobilization (granulocyte-colony-stimulating factor [G-CSF], G-CSF plus plerixafor, or cyclophosphamide G-CSF/granulocyte-macrophage [GM]-CSF) on number of colony-forming unit-GM, engraftment, and Day +100 hematopoietic graft function.
Alexander ET, Towery JA, Miller AN, Kramer C, Hogan KR, Squires JE, Stuart RK, Costa LJ. Alexander ET, et al. Transfusion. 2011 Sep;51(9):1995-2000. doi: 10.1111/j.1537-2995.2011.03085.x. Epub 2011 Mar 10. Transfusion. 2011. PMID: 21392017
High intensity regimens with autologous hematopoietic stem cell transplantation as treatment of multiple myeloma.
Awedan AA. Awedan AA. Ann Transplant. 2002;7(2):38-43. Ann Transplant. 2002. PMID: 12416471 Review.
Restoring stem cell mobilization to promote vascular repair in diabetes.
Albiero M, Avogaro A, Fadini GP. Albiero M, et al. Vascul Pharmacol. 2013 Apr;58(4):253-8. doi: 10.1016/j.vph.2013.01.003. Epub 2013 Jan 29. Vascul Pharmacol. 2013. PMID: 23369723 Review.

See all similar articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
Medical
- MedlinePlus Health Information